Quantbot Technologies LP lowered its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 50.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,554 shares of the technology company's stock after selling 15,776 shares during the period. Quantbot Technologies LP's holdings in Relx were worth $706,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in RELX. Wayfinding Financial LLC purchased a new position in shares of Relx in the 4th quarter worth $200,000. TD Private Client Wealth LLC raised its holdings in shares of Relx by 7.7% in the 4th quarter. TD Private Client Wealth LLC now owns 4,943 shares of the technology company's stock worth $224,000 after purchasing an additional 354 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Relx by 95.9% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 7,743 shares of the technology company's stock valued at $352,000 after purchasing an additional 3,791 shares in the last quarter. Whittier Trust Co. grew its holdings in shares of Relx by 44.9% during the 4th quarter. Whittier Trust Co. now owns 35,880 shares of the technology company's stock worth $1,629,000 after purchasing an additional 11,114 shares during the period. Finally, Northwest & Ethical Investments L.P. increased its position in Relx by 5.6% during the 4th quarter. Northwest & Ethical Investments L.P. now owns 210,600 shares of the technology company's stock worth $9,565,000 after purchasing an additional 11,139 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company's stock.
Relx Stock Up 0.3 %
Shares of RELX traded up $0.14 during mid-day trading on Friday, reaching $50.21. 560,996 shares of the stock traded hands, compared to its average volume of 757,401. The stock has a fifty day simple moving average of $49.48 and a 200 day simple moving average of $47.83. Relx Plc has a 12-month low of $40.25 and a 12-month high of $51.99. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The firm has a market cap of $93.18 billion, a price-to-earnings ratio of 26.99, a P/E/G ratio of 2.73 and a beta of 0.90.
Relx Increases Dividend
The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This is an increase from Relx's previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. This represents a yield of 1.6%. Relx's payout ratio is 59.68%.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on RELX shares. The Goldman Sachs Group began coverage on shares of Relx in a research report on Wednesday. They set a "buy" rating on the stock. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, Redburn Atlantic began coverage on Relx in a research note on Wednesday, January 8th. They set a "buy" rating on the stock. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy".
Read Our Latest Stock Analysis on RELX
Relx Company Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
